Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Ortho Clinical Diagnostics Holdings plc | ocdx-ex322_176.htm |
| EX-31.2 - EX-31.2 - Ortho Clinical Diagnostics Holdings plc | ocdx-ex312_177.htm |
| EX-31.1 - EX-31.1 - Ortho Clinical Diagnostics Holdings plc | ocdx-ex311_178.htm |
| 10-Q - 10-Q - Ortho Clinical Diagnostics Holdings plc | ocdx-10q_20210404.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the filing of the Quarterly Report on Form 10-Q of Ortho Clinical Diagnostics Holdings plc (the “Company”) for the period ended April 4, 2021 with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned Chairman and Chief Executive Officer of the Company hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that based on his knowledge:
(1) the Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934, as amended; and
(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: May 18, 2021 |
|
By: |
/s/ Chris Smith |
|
|
|
|
Chris Smith |
|
|
|
|
Chairman and Chief Executive Officer |